美农生物
(301156)
| 流通市值：9.63亿 | | | 总市值：20.33亿 |
| 流通股本：6878.20万 | | | 总股本：1.45亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 248,647,790.61 | 227,453,513.39 | 377,541,958.9 | 359,853,060.69 |
| 结算备付金 | 0 | 0 | 0 | 0 |
| 拆出资金 | 0 | 0 | 0 | 0 |
| 衍生金融资产 | 0 | 0 | 0 | 0 |
| 应收票据及应收账款 | 95,354,608.51 | 81,998,881.54 | 70,173,311.54 | 78,034,775.75 |
| 其中：应收票据 | 538,410 | 406,710 | 350,000 | 200,000 |
| 应收账款 | 94,816,198.51 | 81,592,171.54 | 69,823,311.54 | 77,834,775.75 |
| 应收款项融资 | 498,400 | 477,175 | 386,775 | 669,900 |
| 预付款项 | 4,540,314.18 | 9,475,178.82 | 8,911,324.32 | 8,467,858.25 |
| 应收保费 | 0 | 0 | 0 | 0 |
| 应收分保账款 | 0 | 0 | 0 | 0 |
| 应收分保合同准备金 | 0 | 0 | 0 | 0 |
| 其他应收款合计 | 216,288.23 | 286,190.81 | 379,780.21 | 247,061.41 |
| 其中:应收利息 | 0 | 0 | 0 | 0 |
| 应收股利 | 0 | 0 | 0 | 0 |
| 买入返售金融资产 | 0 | 0 | 0 | 0 |
| 存货 | 79,385,746.39 | 78,049,151.95 | 69,068,331.15 | 77,712,454.91 |
| 合同资产 | 0 | 0 | 0 | 0 |
| 一年内到期的非流动资产 | 0 | 0 | 0 | 0 |
| 其他流动资产 | 2,331,637.28 | 3,796,411.93 | 5,868,027.2 | 5,486,641.85 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 512,278,106.91 | 496,713,347.54 | 557,442,486.51 | 560,530,252.86 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | 0 | 0 | 0 |
| 债权投资 | 0 | 0 | 0 | 0 |
| 其他债权投资 | 0 | 0 | 0 | 0 |
| 长期应收款 | 0 | 0 | 0 | 0 |
| 长期股权投资 | 22,190,284.23 | 22,159,261.43 | 22,281,193.94 | 22,950,299 |
| 其他权益工具投资 | 0 | 0 | 0 | 0 |
| 其他非流动金融资产 | 2,465,028.46 | 2,232,452.6 | 2,443,359.68 | 1,912,627.92 |
| 投资性房地产 | 0 | 0 | 0 | 0 |
| 固定资产 | 199,314,358.22 | 204,603,619.48 | 200,572,064.68 | 205,485,116.69 |
| 在建工程 | 9,204,449.77 | 2,145,420.54 | 12,431,306.33 | 11,677,844.87 |
| 生产性生物资产 | 0 | 0 | 0 | 0 |
| 油气资产 | 0 | 0 | 0 | 0 |
| 使用权资产 | 863,936.15 | 1,083,020.06 | 1,302,103.97 | 1,521,187.88 |
| 无形资产 | 30,078,202.42 | 30,451,476.64 | 28,228,138.04 | 28,556,081.72 |
| 开发支出 | 0 | 0 | 0 | 0 |
| 商誉 | 0 | 0 | 0 | 0 |
| 长期待摊费用 | 2,435,290.04 | 2,568,076.35 | 1,564,320.52 | 1,481,938.41 |
| 递延所得税资产 | 2,451,712.11 | 2,332,734.38 | 2,156,233.78 | 3,367,986.26 |
| 其他非流动资产 | 638,245.48 | 3,132,283.01 | 1,668,825.18 | 1,340,497.1 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 269,641,506.88 | 270,708,344.49 | 272,647,546.12 | 278,293,579.85 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 781,919,613.79 | 767,421,692.03 | 830,090,032.63 | 838,823,832.71 |
| 流动负债: | | | | |
| 短期借款 | 0 | 0 | 1,000,886.11 | 0 |
| 向中央银行借款 | 0 | 0 | 0 | 0 |
| 吸收存款及同业存放 | 0 | 0 | 0 | 0 |
| 拆入资金 | 0 | 0 | 0 | 0 |
| 交易性金融负债 | 0 | 0 | 0 | 0 |
| 衍生金融负债 | 0 | 0 | 0 | 0 |
| 应付票据及应付账款 | 25,972,532.3 | 18,103,725.37 | 15,020,859.92 | 17,067,449.87 |
| 其中：应付票据 | 0 | 0 | 0 | 0 |
| 应付账款 | 25,972,532.3 | 18,103,725.37 | 15,020,859.92 | 17,067,449.87 |
| 预收款项 | 0 | 0 | 0 | 0 |
| 合同负债 | 1,037,542.11 | 922,815.44 | 667,218.91 | 715,274.69 |
| 卖出回购金融资产款 | 0 | 0 | 0 | 0 |
| 应付手续费及佣金 | 0 | 0 | 0 | 0 |
| 应付职工薪酬 | 10,078,230.84 | 7,673,551.72 | 6,087,484.47 | 16,165,165.01 |
| 应交税费 | 1,378,627.62 | 531,835.5 | 345,879.14 | 1,941,343.87 |
| 其他应付款合计 | 885,096.87 | 695,833.51 | 728,996.18 | 902,763.61 |
| 其中:应付利息 | 0 | 0 | 0 | 0 |
| 应付股利 | 0 | 0 | 0 | 0 |
| 应付分保账款 | 0 | 0 | 0 | 0 |
| 保险合同准备金 | 0 | 0 | 0 | 0 |
| 代理买卖证券款 | 0 | 0 | 0 | 0 |
| 代理承销证券款 | 0 | 0 | 0 | 0 |
| 一年内到期的非流动负债 | 574,931.85 | 488,694.27 | 905,770.55 | 897,333.85 |
| 其他流动负债 | 385,695.8 | 365,394.31 | 216,651.01 | 225,189.06 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 40,312,657.39 | 28,781,850.12 | 24,973,746.29 | 37,914,519.96 |
| 非流动负债: | | | | |
| 长期借款 | 0 | 0 | 0 | 0 |
| 应付债券 | 0 | 0 | 0 | 0 |
| 优先股 | 0 | 0 | 0 | 0 |
| 永续债 | 0 | 0 | 0 | 0 |
| 租赁负债 | 152,969.6 | 232,040.16 | 229,543.86 | 227,074.44 |
| 长期应付款 | 0 | 0 | 0 | 0 |
| 长期应付职工薪酬 | 0 | 0 | 0 | 0 |
| 预计负债 | 0 | 0 | 0 | 0 |
| 递延收益 | 1,401,653.27 | 1,454,007.17 | 1,515,499.97 | 1,576,992.77 |
| 递延所得税负债 | 0 | 0 | 0 | 0 |
| 其他非流动负债 | 0 | 0 | 0 | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,554,622.87 | 1,686,047.33 | 1,745,043.83 | 1,804,067.21 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 41,867,280.26 | 30,467,897.45 | 26,718,790.12 | 39,718,587.17 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 145,191,440 | 145,191,440 | 112,000,000 | 112,000,000 |
| 其他权益工具 | 0 | 0 | 0 | 0 |
| 优先股 | 0 | 0 | 0 | 0 |
| 永续债 | 0 | 0 | 0 | 0 |
| 资本公积 | 364,833,186.66 | 364,833,186.66 | 398,024,626.66 | 398,024,626.66 |
| 减:库存股 | 29,813,559.97 | 21,292,185.85 | 5,317,926.24 | 0 |
| 其他综合收益 | 0 | 0 | 0 | 0 |
| 专项储备 | 0 | 0 | 0 | 0 |
| 盈余公积 | 39,184,573.11 | 39,184,573.11 | 39,184,573.11 | 39,184,573.11 |
| 一般风险准备 | 0 | 0 | 0 | 0 |
| 未分配利润 | 220,656,693.73 | 209,036,780.66 | 259,479,968.98 | 249,896,045.77 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 740,052,333.53 | 736,953,794.58 | 803,371,242.51 | 799,105,245.54 |
| 少数股东权益 | 0 | 0 | 0 | 0 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 740,052,333.53 | 736,953,794.58 | 803,371,242.51 | 799,105,245.54 |
| 负债和股东权益合计 | 781,919,613.79 | 767,421,692.03 | 830,090,032.63 | 838,823,832.71 |
| 公告日期 | 2024-10-30 | 2024-08-28 | 2024-04-25 | 2024-04-09 |
| 审计意见(境内) | | | | 标准无保留意见 |